AB Science - Company & Market Research Reports

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

  • Drug Pipelines
  • 722 Pages
From
Alzheimer s: Epidemiology Overview and Insights - Product Thumbnail Image

Alzheimer s: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Alzheimer's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Alzheimer's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

  • Drug Pipelines
  • 713 Pages
From
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • 144 Pages
From
Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies - Product Thumbnail Image

Alzheimer's Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies

  • Report
  • 151 Pages
From
Alzheimer's Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents - Product Thumbnail Image

Alzheimer's Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents

  • Report
  • 144 Pages
From
Global Malignant Melanoma Drug Market & Clinical Pipeline Insight - Product Thumbnail Image

Global Malignant Melanoma Drug Market & Clinical Pipeline Insight

  • Drug Pipelines
  • 500 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Drug Pipelines
  • 1020 Pages
From
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant - Product Thumbnail Image

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • Report
  • 122 Pages
From
Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026 - Product Thumbnail Image

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026

  • Report
  • 240 Pages
From
COPD: Pipeline Assessment and Insights - Product Thumbnail Image

COPD: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Alzheimer's Disease - Pipeline Review, H2 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2018

  • Drug Pipelines
  • 1333 Pages
From
Neuroprotective Agents: Therapeutic Applications and Global Markets - Product Thumbnail Image

Neuroprotective Agents: Therapeutic Applications and Global Markets

  • Report
  • 133 Pages
From
Global Asthma and COPD Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Asthma and COPD Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Systemic Mastocytosis Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Systemic Mastocytosis Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 107 Pages
From
Loading Indicator
adroll